Postantibiotic effect of ceftriaxone and gentamicin alone and in combination on Klebsiella pneumoniae, Pseudomonas aeruginosa and Streptococcus viridans

Infection

Volumn 24, Issue 6, 1996, Pages 459-464

  Buxbaum, A ^a   Georgopoulos, A ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE; GENTAMICIN;

ALPHA HEMOLYTIC STREPTOCOCCUS; ARTICLE; BACTERIAL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DILUTION; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POSTANTIBIOTIC EFFECT; PSEUDOMONAS AERUGINOSA; STRAIN DIFFERENCE;

ANTI-BACTERIAL AGENTS; CEFTRIAXONE; CEPHALOSPORINS; COLONY COUNT, MICROBIAL; DRUG EVALUATION, PRECLINICAL; DRUG THERAPY, COMBINATION; GENTAMICINS; HUMANS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS; TIME FACTORS;

EID: 0030451592     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01713048     Document Type: Article

References (40)

1. Bigger, J. W.: The bactericidal action of penicillin on Staphylococcus pyogenes. Ir. J. Med. Sc. 227 (1944) 533-568.
2. Parker, R. F., Luse, S.: The action of penicillin on Straphylococcus: further observations on the effect of a short exposure. J. Bacteriol. 56 (1948) 75-81.
3. Eagle, H., Musselmann, A. D.: The slow recovery of bacteria from the toxic effects of penicillin. J. Bacteriol. 58 (1949) 475-490.
4. Bodey, G. P., Pan, T.: Effect of cephalothin on growth patterns of microorganisms. J. Antibiotics 29 (1976) 1092-1095.
5. McDonald, P. J., Craig, W. A., Kunin, C. M.: Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time. J. Infect. Dis. 135 (1977) 217-223.
6. Rolinson, G. N.: Plasma concentrations of penicillin in relation to the antibacterial effect. In: Davies, D. S., Prichard, B. N. C. (eds.): Biological effects of drugs in relation to their plasma concentrations. University Park Press, Baltimore 1973, pp. 183-189.
7. Krogstad, D. J., Moellering, R. C.: Combinations of antibiotics, mechanisms of interaction against bacteria. In: Lorian, V. M. (ed.): Antibiotics in laboratory medicine. Williams & Wilkins, Baltimore 1980, pp. 298-341.
8. Hook, E. W., Roberts, R. B., Sande, M. A.: Antimicrobial therapy of experimental enterococcal endocarditis. Antimicrob. Agents Chemother. 8 (1975) 564-570.
9. Johnson, D. E., Thompson, B., Calia, F. M.: Comparative activities of piperacillin, ceftazidime, and amikacin, alone and in all possible combinations, against experimental Pseudomondas aeruginosa infections in neutropenic rats. Antimicrob. Agents Chemother. 28 (1985) 735-739.
10. Klastersky, J., Meunier-Carpentier, F., Prevost, J.-M.: Significance of antimicrobial synergism for the outcome of gram-negative sepsis. Am. J. Med. Sc. 273 (1977) 157-167.
11. Fuursted, K.: Comparison of the post-antibiotic effect of Streptococcus faecalis and Streptococcus faecium with ampicillin alone or combined with streptomycin: studies on a novel type of antimicrobial interaction. Acta Path. Microbiol. Immunol. Scand. Section B 95 (1987) 351-354.
12. Fuursted, K.: Comparative killing activity and post-antibiotic effect of streptomycin combined with ampicillin, ciprofloxacin, imipenem, piperacillin or vancomycin against strains of Streptococcus faecalis and Streptococcus faecium. Chemotherapy 34 (1988) 229-234.
13. Hessen, M. T., Pitsakis, P. G., Levison, M. E.: Potentiation of post-antibiotic effect with antibiotic combinations. 26th ICAAC., USA 1986, abstr. 584.
14. Hessen, M. T., Pitsakis, P. G., Levison, M. E.: Postantibiotic effect of penicillin plus gentamicin versus Enterococcus fecalis in vitro and in vivo. Antimicrob. Agents Chemother. (1989) 608-611.
15. Isaksson, B., Hanberger, H., Maller, R., Nilsson, L. E., Nilsson, M.: Synergistic postantibiotic effect of amikacin and β-lactam antibiotics on Enterococcus faecalis. J. Antimicrob. Chemother. 27 (Suppl. C9) (1991) 9-14.
16. Wistanley, T. G., Hastings, J. G. M.: Penicillin-aminoglycoside synergy and postantibiotic effect for enterococci. J. Antimicrob. Chemother. 23 (1989) 189-199.
17. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: Tentative Standard M7-T4. NCCLS (1988), Villanova, PA.
18. Bundtzen, R. W., Gerber, A. U., Cohn, D. L., Craig, W. A.: Postantibiotic suppression of bacterial growth. Rev. Infect. Dis. 3 (1981) 28-37.
19. Eagle, H.: The recovery of bacteria from the toxic effects of penicillin. J. Clin. Invest. 28 (1949) 832-836.
20. Baquero, F., Culebras, E., Patron, C., Perez-Diaz, J. C., Medrano, J. C., Vicente, M. F.: Postantibiotic effect on gram-positive and gram-negative micro-organisms. J. Antimicrob. Chemother. 18 (Suppl. E) (1986) 47-49.
21. Bustamante, C. L., Drusano, G. L., Tatem, B. A., Standiford, H. C.: Postantibiotic effect of imipenem on Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 26 (1984) 678-682.
22. Eagle, H., Fleischmann, R., Musselman, A. D.: The bacterial action of penicillin in vivo, the participation of the host and the slow recovery of the surviving organisms. Ann. Intern. Med. 33 (1950) 544-571.
23. Craig, W. A.: Concluding remarks from the pharmacokinetic and experimental data on beta-lactam antibiotics in the treatment of patients. Eur. J. Clin. Microbiol. 3 (1984) 575-578.
24. Bailey and Scott: Diagnostic Microbiology, 9th ed., Mosby, St. Louis, 1994.
25. Kuenzi, B., Segessenmann, Ch., Gerber, A. U.: Postantibiotic effect of roxithromycin, erythromycin, and clindamycin against selected gram-positive bacteria and Haemophilus influenzae. J. Antimicrob. Chemother. 20 (Suppl. B) (1987) 39-46.
26. Isaksson, B., Nilsson, L., Maller, R., Sören, L.: Postantibiotic effect of aminoglycosides on gram-negative bacteria evaluated by a new method. J. Antimicrob. Chemother. 22 (1988) 23-33.
27. Isaksson, B., Hanberger, H., Maller, R., Nilsson, L. E., Nilsson, M.: Synergic postantibiotic effect of amikacin in combination with β-lactam antibiotics on gram-negative bacteria. J. Antimicrob. Chemother. 28 (1991) 25-34.
28. Craig, W. A., Gudmundssonn, S.: The postantibiotic effect. 3rd ed. In: Lorian, V. (ed.): Antibiotics in laboratory medicine, Williams & Wilkins, Baltimore 1991, 403-431.
29. White, G. M., Malow, J. B., Zimelis, V. M., Pahlavanzadeh, H., Panwalker, A. P., Jackson, G.: Comparative in vitro activity of azlocillin, ampicillin, mezlocillin, piperacillin, and ticarcillin, alone and in combination with an aminoglycoside. Antimicrob. Agents Chemother. 15 (1979) 540-543.
30. Paglia, P., Molinari, G., Pesce, A., Debbia, E. A.: Dactimicin, a new aminoglycoside: in vitro activity, postantibiotic effect and interaction with other antibiotics. Eur. J. Clin. Microbiol. Infect. Dis. 8 (1989) 639-643.
31. McLaughlin, J. E., Reeves, D. S.: Clinical and laboratory evidence for inactivation of gentamicin by carbenicillin. Lancet i (1971) 261-264.
32. Weibert, R., Keane, W., Shapiro, F.: Carbenicillin inactivation of aminoglycosides in patients with severe renal failure. Transactions of the Am. Soc. Artific. Int. Org. 22 (1976) 439-443.
33. Pechere, J. C., Craig, W. A., Meunier, F.: Once daily dosing of aminoglycoside: one step forward. J. Antimicrob. Chemother. 27 (Suppl. C) (1991) 149-152.
34. McDonald, P. J., Wetherall, B. L., Pruul, H.: Postantibiotic leukocyte enhancement: increased susceptibility of bacteria pretreated with antibiotics to activity of leukocytes. Rev. Infect. Dis. 3 (1981) 38-44.
35. Gerber, A. U., Craig, W. A.: Growth kinetics of respiratory pathogens after short exposures to ampicillin and erythromycin in vitro. J. Antimicrob. Chemother. 8 (Suppl. C) (1981) 81-91.
36. Craig, W. A.: Post antibiotic effects in experimental infection models: relationship to in-vitro phenomena and to treatment of infections in man. J. Antimicrob. Chemother. 31 (Suppl. D) (1993) 149-158.
37. Gilbert, D. N.: Once-daily aminoglycoside therapy. Antimicrob. Agents Chemother. 35 (1991) 399-405.
38. Pechere, J. C., Bernard, P. A.: Gentamicin ototoxicity can be avoided if a new therapeutic regimen is used. An experimental animal model. 24th ICAAC, USA 1984, abstr. 484.
39. ter Braak, E. W., de Vries, P. J., Bouter, K. P., van der Vegt, S. G., Dorrestein, G. C., Nortier, J. W.: Once daily dosing regimen for aminoglycoside plus β-lactam combination therapy of serious bacterial infections: comparative trial with netilmicin plus ceftriaxone. Am. J. Med. 89 (1990) 58-66.
40. Tulkens, P. M.: Efficacy and safety of aminoglycosides once-a-day: experimental and clinical data. Scand. J. Infect. Dis. 74 (1991) 249-257.